2014
DOI: 10.1016/j.ejphar.2014.06.014
|View full text |Cite
|
Sign up to set email alerts
|

The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(28 citation statements)
references
References 37 publications
0
28
0
Order By: Relevance
“…When EGCG was incubated with rat liver microsomes at 1–100 μM for 30 min in vitro, EGCG selectively bound to COMT [81]. However, in vivo tests showed that supplementation with a high dose of EGCG does not impair the activity of COMT [82]. A bioavailability test using 3 H-EGCG in mice revealed a wide distribution of radioactivity in target organs, including digestive tract, liver, lung, pancreas, mammary gland, brain, kidney, uterus, and ovary.…”
Section: Inconsistent Results and Further Study Suggestionsmentioning
confidence: 99%
“…When EGCG was incubated with rat liver microsomes at 1–100 μM for 30 min in vitro, EGCG selectively bound to COMT [81]. However, in vivo tests showed that supplementation with a high dose of EGCG does not impair the activity of COMT [82]. A bioavailability test using 3 H-EGCG in mice revealed a wide distribution of radioactivity in target organs, including digestive tract, liver, lung, pancreas, mammary gland, brain, kidney, uterus, and ovary.…”
Section: Inconsistent Results and Further Study Suggestionsmentioning
confidence: 99%
“…Hodgson et al (40), using targeted catecholamine profiling techniques, determined that GTE did not increase concentrations of norepinephrine, which suggests that GTE supplementation may not alter COMT activity. Furthermore, Lorenz et al (41) determined that the administration of 750 mg EGCG did not impair the in vivo activity of COMT. Epidemiologic studies have linked green tea consumption to higher bone density (14) and reduced risk of hip fractures (42).…”
Section: Discussionmentioning
confidence: 99%
“…Qualitative synthesis showed that findings were inconsistent, were not replicated, or lacked statistical evidence to substantiate reported genotype differences (Table S11 in Supplement 2). (20)(21)(22)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57)(58)(59)(60)…”
Section: No Consistent Evidence For Functional Polymorphisms In Dopammentioning
confidence: 99%